Nasal Spray Influenza Vaccine Market Report 2026
Download Free Sample Buy Now
Nasal Spray Influenza Vaccine Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Nasal Spray Influenza Vaccine Market Report 2026

Global Outlook – By Type (Live Attenuated Influenza Vaccine (LAIV), Inactivated Influenza Vaccine), By Administration Method (Single-Dose Administration, Multi-Dose Administration), By Age Group (Pediatric, Adult, Geriatric), By Distribution Channel (Hospitals, Clinics, Pharmacies, Online Stores, Other Distribution Channels), By End User (Healthcare Providers, Individuals, Government Health Departments, Pharmaceutical Companies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Nasal Spray Influenza Vaccine Market Overview

• Nasal Spray Influenza Vaccine market size has reached to $1.48 billion in 2025

• Expected to grow to $2.68 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%

• Growth Driver: Increasing Prevalence Of Influenza Is Fueling The Market Growth Due To Rising Infection Rates And Virus Mutations

• Market Trend: The Role Of Live Attenuated Influenza Vaccines In Immune Response

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nasal Spray Influenza Vaccine Market?

Nasal spray influenza vaccine refers to a needle-free flu vaccine administered through the nose that uses live attenuated viruses to protect against seasonal influenza. Nasal spray influenza vaccine is utilized by spraying it into the nostrils, where it stimulates an immune response in the nasal passages to protect against seasonal flu.

The main types of nasal spray influenza vaccines include the live attenuated influenza vaccine (LAIV) and the inactivated influenza vaccine. The live attenuated influenza vaccine (LAIV) is a needle-free flu vaccine that uses weakened live viruses to trigger strong systemic and mucosal immune responses. These vaccines are administered through various methods, such as single-dose and multi-dose administration. They are intended for different age groups, including pediatric, adult, and geriatric populations. Distribution channels include hospitals, clinics, pharmacies, online stores, and other outlets. The end users of nasal spray influenza vaccines include healthcare providers, individuals, government health departments, and pharmaceutical companies.

Nasal Spray Influenza Vaccine Market Global Report 2026 Market Report bar graph

What Is The Nasal Spray Influenza Vaccine Market Size and Share 2026?

The nasal spray influenza vaccine market size has grown rapidly in recent years. It will grow from $1.48 billion in 2025 to $1.66 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing flu vaccination awareness, reliance on traditional injection-based flu vaccines, government-led influenza immunization programs, seasonal flu outbreaks, limited availability of needle-free options.

What Is The Nasal Spray Influenza Vaccine Market Growth Forecast?

The nasal spray influenza vaccine market size is expected to see rapid growth in the next few years. It will grow to $2.68 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to growing demand for needle-free delivery systems, expansion of pediatric and geriatric immunization programs, rising investment in nasal vaccine r&d, development of advanced attenuated vaccine formulations, increasing global vaccination coverage initiatives. Major trends in the forecast period include growing adoption of needle-free vaccination methods, rising demand for pediatric-friendly flu vaccines, expanding use of quadrivalent live attenuated vaccines, increasing seasonal flu prevention campaigns, development of multi-dose and single-dose nasal formulations.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Nasal Spray Influenza Vaccine Market Segmentation

1) By Type: Live Attenuated Influenza Vaccine (LAIV), Inactivated Influenza Vaccine

2) By Administration Method: Single-Dose Administration, Multi-Dose Administration

3) By Age Group: Pediatric, Adult, Geriatric

4) By Distribution Channel: Hospitals, Clinics, Pharmacies, Online Stores, Other Distribution Channels

5) By End User: Healthcare Providers, Individuals, Government Health Departments, Pharmaceutical Companies

Subsegments:

1) By Live Attenuated Influenza Vaccine (LAIV): Trivalent Live Attenuated Influenza Vaccine (Trivalent LAIV), Quadrivalent Live Attenuated Influenza Vaccine (Quadrivalent LAIV)

2) By Inactivated Influenza Vaccine: Whole Virus Inactivated Vaccine, Split Virus Inactivated Vaccine, Subunit Inactivated Vaccine, Adjuvanted Inactivated Vaccine, High-Dose Inactivated Vaccine

What Is The Driver Of The Nasal Spray Influenza Vaccine Market?

The increasing prevalence of influenza is expected to propel the growth of nasal spray influenza vaccine going forward. Influenza refers to a highly contagious viral infection that primarily affects the respiratory system, causing symptoms such as fever, cough, sore throat, body aches, and fatigue. The increasing prevalence of influenza is primarily due to the frequent genetic mutations of the influenza virus, which enable it to evade existing immunity and spread rapidly among populations. Nasal spray influenza vaccine helps protect against influenza by delivering a weakened form of the virus directly into the nasal passages, stimulating an immune response where the virus typically enters the body. For instance, in September 2024, according to the data published by the Centers for Disease Control and Prevention (CDC), a US-based nation's health protection agency, preliminary estimates for the 2023–2024 U.S. influenza season suggest that between 34 million and 75 million symptomatic illnesses, 15 million to 33 million medical visits, 380,000 to 900,000 hospitalizations, and 17,000 to 100,000 deaths occurred, with older adults (=65 years) accounting for 51% of hospitalizations and 68% of deaths. Therefore, the increasing prevalence of influenza is driving the growth of the nasal spray influenza vaccine industry.

Key Players In The Global Nasal Spray Influenza Vaccine Market

Major companies operating in the nasal spray influenza vaccine market are Sanofi Pasteur SA, GSK plc, FluGen Inc., BioDiem Ltd, Codagenix Inc, Altimmune Inc, AstraZeneca PLC, MedImmune LLC, BCHT Biotechnology Co Ltd, Serum Institute of India Pvt Ltd, Vivaldi Biosciences, Vaccitech, Blue Water Vaccines, VaxInnate, INOVIO Pharmaceuticals, Cipla Ltd, Beijing Wantai Biological Pharmacy Enterprise Co Ltd, Bharat Biotech, Novavax Inc, BioNTech SE, Transgene SA, BiondVax Pharmaceuticals Ltd, Adimmune Corporation, Teva Pharmaceutical Industries Ltd

Global Nasal Spray Influenza Vaccine Market Trends and Insights

Major companies operating in the nasal spray influenza vaccine market are focusing on developing innovative formulations such as live attenuated influenza vaccine to enhance immune response and improve patient compliance. A live attenuated influenza vaccine (LAIV) is a flu vaccine made from live, weakened influenza viruses that helps prevent influenza by stimulating the immune system to produce antibodies, providing protection without causing the disease, and offering a more comprehensive immune response through both local and systemic immunity, which enhances the body's ability to defend against future flu infections. For instance, in September 2024, AstraZeneca Plc, a UK-based pharmaceutical industry company, received approval from the U.S. Food and Drug Administration (FDA) for FluMist, a live attenuated influenza vaccine (LAIV), to be self-administered by adults aged up to 49 years or administered by caregivers to children aged 2 to 17 years, making it the first and only influenza vaccine approved for self- or caregiver-administration in the United States. This approval was based on comprehensive usability studies that demonstrated the ability of individuals to correctly self-administer the vaccine, with 100% of participants delivering a full dose as instructed.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Nasal Spray Influenza Vaccine Market?

In October 2023, Mylab Discovery Solutions Private Limited, an India-based biotechnology company, partnered with Serum Institute of India Private Limited to launch Nasovac S4, India's first nasal influenza vaccine. With this partnership, Mylab Discovery Solutions Private Limited and Serum Institute of India Private Limited aim to offer comprehensive protection against a wide range of influenza strains through the introduction of Nasovac S4, India's first needle-free nasal influenza vaccine. Serum Institute of India Private Limited is an India-based biotechnology company that specializes in providing Nasovac-S and Nasovac-S4 nasal influenza vaccines.

Regional Outlook

North America was the largest region in the nasal spray influenza vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nasal Spray Influenza Vaccine Market?

The nasal spray influenza vaccine market consists of sales of flumist quadrivalent, fluenz tetra, vaxinate, centripetal flu nasal spray vaccine, nasovac-s, fluvac nasal spray, and live attenuated influenza vaccine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nasal Spray Influenza Vaccine Market Report 2026?

The nasal spray influenza vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nasal spray influenza vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Nasal Spray Influenza Vaccine Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.66 billion
Revenue Forecast In 2035 $2.68 billion
Growth Rate CAGR of 12.7% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Administration Method, Age Group, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Sanofi Pasteur SA, GSK plc, FluGen Inc., BioDiem Ltd, Codagenix Inc, Altimmune Inc, AstraZeneca PLC, MedImmune LLC, BCHT Biotechnology Co Ltd, Serum Institute of India Pvt Ltd, Vivaldi Biosciences, Vaccitech, Blue Water Vaccines, VaxInnate, INOVIO Pharmaceuticals, Cipla Ltd, Beijing Wantai Biological Pharmacy Enterprise Co Ltd, Bharat Biotech, Novavax Inc, BioNTech SE, Transgene SA, BiondVax Pharmaceuticals Ltd, Adimmune Corporation, Teva Pharmaceutical Industries Ltd
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Nasal Spray Influenza Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Nasal Spray Influenza Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Nasal Spray Influenza Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Nasal Spray Influenza Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Growing Adoption Of Needle-Free Vaccination Methods

4.2.2 Rising Demand For Pediatric-Friendly Flu Vaccines

4.2.3 Expanding Use Of Quadrivalent Live Attenuated Vaccines

4.2.4 Increasing Seasonal Flu Prevention Campaigns

4.2.5 Development Of Multi-Dose And Single-Dose Nasal Formulations

5. Nasal Spray Influenza Vaccine Market Analysis Of End Use Industries

5.1 Healthcare Providers

5.2 Individuals

5.3 Government Health Departments

5.4 Pharmaceutical Companies

5.5 Pediatric & Adult Vaccination Centers

6. Nasal Spray Influenza Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nasal Spray Influenza Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Nasal Spray Influenza Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Nasal Spray Influenza Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Nasal Spray Influenza Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Nasal Spray Influenza Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nasal Spray Influenza Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nasal Spray Influenza Vaccine Market Segmentation

9.1. Global Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Live Attenuated Influenza Vaccine (LAIV), Inactivated Influenza Vaccine

9.2. Global Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single-Dose Administration, Multi-Dose Administration

9.3. Global Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric, Adult, Geriatric

9.4. Global Nasal Spray Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Pharmacies, Online Stores, Other Distribution Channels

9.5. Global Nasal Spray Influenza Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Healthcare Providers, Individuals, Government Health Departments, Pharmaceutical Companies

9.6. Global Nasal Spray Influenza Vaccine Market, Sub-Segmentation Of Live Attenuated Influenza Vaccine (LAIV), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Trivalent Live Attenuated Influenza Vaccine (Trivalent LAIV), Quadrivalent Live Attenuated Influenza Vaccine (Quadrivalent LAIV)

9.7. Global Nasal Spray Influenza Vaccine Market, Segmentation By Inactivated Influenza Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Whole Virus Inactivated Vaccine, Split Virus Inactivated Vaccine, Subunit Inactivated Vaccine, Adjuvanted Inactivated Vaccine, High-Dose Inactivated Vaccine

10. Nasal Spray Influenza Vaccine Market Regional And Country Analysis

10.1. Global Nasal Spray Influenza Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Nasal Spray Influenza Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nasal Spray Influenza Vaccine Market

11.1. Asia-Pacific Nasal Spray Influenza Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nasal Spray Influenza Vaccine Market

12.1. China Nasal Spray Influenza Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nasal Spray Influenza Vaccine Market

13.1. India Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nasal Spray Influenza Vaccine Market

14.1. Japan Nasal Spray Influenza Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nasal Spray Influenza Vaccine Market

15.1. Australia Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nasal Spray Influenza Vaccine Market

16.1. Indonesia Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nasal Spray Influenza Vaccine Market

17.1. South Korea Nasal Spray Influenza Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nasal Spray Influenza Vaccine Market

18.1. Taiwan Nasal Spray Influenza Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nasal Spray Influenza Vaccine Market

19.1. South East Asia Nasal Spray Influenza Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nasal Spray Influenza Vaccine Market

20.1. Western Europe Nasal Spray Influenza Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nasal Spray Influenza Vaccine Market

21.1. UK Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nasal Spray Influenza Vaccine Market

22.1. Germany Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nasal Spray Influenza Vaccine Market

23.1. France Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nasal Spray Influenza Vaccine Market

24.1. Italy Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nasal Spray Influenza Vaccine Market

25.1. Spain Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nasal Spray Influenza Vaccine Market

26.1. Eastern Europe Nasal Spray Influenza Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nasal Spray Influenza Vaccine Market

27.1. Russia Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nasal Spray Influenza Vaccine Market

28.1. North America Nasal Spray Influenza Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nasal Spray Influenza Vaccine Market

29.1. USA Nasal Spray Influenza Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nasal Spray Influenza Vaccine Market

30.1. Canada Nasal Spray Influenza Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nasal Spray Influenza Vaccine Market

31.1. South America Nasal Spray Influenza Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nasal Spray Influenza Vaccine Market

32.1. Brazil Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nasal Spray Influenza Vaccine Market

33.1. Middle East Nasal Spray Influenza Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nasal Spray Influenza Vaccine Market

34.1. Africa Nasal Spray Influenza Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Nasal Spray Influenza Vaccine Market, Segmentation By Type, Segmentation By Administration Method, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nasal Spray Influenza Vaccine Market Regulatory and Investment Landscape

36. Nasal Spray Influenza Vaccine Market Competitive Landscape And Company Profiles

36.1. Nasal Spray Influenza Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Nasal Spray Influenza Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Nasal Spray Influenza Vaccine Market Company Profiles

36.3.1. Sanofi Pasteur SA Overview, Products and Services, Strategy and Financial Analysis

36.3.2. GSK plc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. FluGen Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. BioDiem Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Codagenix Inc Overview, Products and Services, Strategy and Financial Analysis

37. Nasal Spray Influenza Vaccine Market Other Major And Innovative Companies

Altimmune Inc, AstraZeneca PLC, MedImmune LLC, BCHT Biotechnology Co Ltd, Serum Institute of India Pvt Ltd, Vivaldi Biosciences, Vaccitech, Blue Water Vaccines, VaxInnate, INOVIO Pharmaceuticals, Cipla Ltd, Beijing Wantai Biological Pharmacy Enterprise Co Ltd, Bharat Biotech, Novavax Inc, BioNTech SE

38. Global Nasal Spray Influenza Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Nasal Spray Influenza Vaccine Market

40. Nasal Spray Influenza Vaccine Market High Potential Countries, Segments and Strategies

40.1 Nasal Spray Influenza Vaccine Market In 2030 - Countries Offering Most New Opportunities

40.2 Nasal Spray Influenza Vaccine Market In 2030 - Segments Offering Most New Opportunities

40.3 Nasal Spray Influenza Vaccine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Nasal Spray Influenza Vaccine Market, Overview Of Key Products - Product Examples
  • Table 2: Global Nasal Spray Influenza Vaccine Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Nasal Spray Influenza Vaccine Market, Supply Chain Analysis
  • Table 4: Global Nasal Spray Influenza Vaccine Market, Major Raw Material Providers
  • Table 5: Global Nasal Spray Influenza Vaccine Market, Major Resource Providers
  • Table 6: Global Nasal Spray Influenza Vaccine Market, Major Manufacturers (Suppliers)
  • Table 7: Global Nasal Spray Influenza Vaccine Market, Major Distributors And Channel Partners
  • Table 8: Global Nasal Spray Influenza Vaccine Market, Key Technologies & Future Trends
  • Table 9: Global Nasal Spray Influenza Vaccine Market, Major Trends
  • Table 10: Global Nasal Spray Influenza Vaccine Market, Major End Users
  • Table 11: Global Nasal Spray Influenza Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Nasal Spray Influenza Vaccine Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Nasal Spray Influenza Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Nasal Spray Influenza Vaccine Market - TAM, US$ Billion, 2025
  • Table 15: Global Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Nasal Spray Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Nasal Spray Influenza Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Nasal Spray Influenza Vaccine Market, Sub-Segmentation Of Live Attenuated Influenza Vaccine (LAIV), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Nasal Spray Influenza Vaccine Market, Segmentation By Inactivated Influenza Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Nasal Spray Influenza Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Nasal Spray Influenza Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Nasal Spray Influenza Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Nasal Spray Influenza Vaccine Market - Company Scoring Matrix
  • Table 98: Sanofi Pasteur SA Financial Performance
  • Table 99: GSK plc Financial Performance
  • Table 100: FluGen Inc. Financial Performance
  • Table 101: BioDiem Ltd Financial Performance
  • Table 102: Codagenix Inc Financial Performance
  • Table 103: Global Nasal Spray Influenza Vaccine Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Nasal Spray Influenza Vaccine Market, Competitive Dashboard
  • Table 105: Global Nasal Spray Influenza Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Nasal Spray Influenza Vaccine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 107: Global, Nasal Spray Influenza Vaccine Market Size Gain ($ Billion), Segmentation By Administration Method, 2025 – 2030
  • Table 108: Global, Nasal Spray Influenza Vaccine Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

List Of Figures

    Figure 1: Global Nasal Spray Influenza Vaccine Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Nasal Spray Influenza Vaccine Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Nasal Spray Influenza Vaccine Market, Supply Chain Analysis
  • Figure 4: Global Nasal Spray Influenza Vaccine Market, Major Raw Material Providers
  • Figure 5: Global Nasal Spray Influenza Vaccine Market, Major Resource Providers
  • Figure 6: Global Nasal Spray Influenza Vaccine Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Nasal Spray Influenza Vaccine Market, Major Distributors And Channel Partners
  • Figure 8: Global Nasal Spray Influenza Vaccine Market, Key Technologies & Future Trends
  • Figure 9: Global Nasal Spray Influenza Vaccine Market, Major Trends
  • Figure 10: Global Nasal Spray Influenza Vaccine Market, Major End Users
  • Figure 11: Global Nasal Spray Influenza Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Nasal Spray Influenza Vaccine Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Nasal Spray Influenza Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Nasal Spray Influenza Vaccine Market - TAM, US$ Billion, 2025
  • Figure 15: Global Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Nasal Spray Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Nasal Spray Influenza Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Nasal Spray Influenza Vaccine Market, Sub-Segmentation Of Live Attenuated Influenza Vaccine (LAIV), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Nasal Spray Influenza Vaccine Market, Segmentation By Inactivated Influenza Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Nasal Spray Influenza Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Nasal Spray Influenza Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Nasal Spray Influenza Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Nasal Spray Influenza Vaccine Market - Company Scoring Matrix
  • Figure 98: Sanofi Pasteur SA Financial Performance
  • Figure 99: GSK plc Financial Performance
  • Figure 100: FluGen Inc. Financial Performance
  • Figure 101: BioDiem Ltd Financial Performance
  • Figure 102: Codagenix Inc Financial Performance
  • Figure 103: Global Nasal Spray Influenza Vaccine Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Nasal Spray Influenza Vaccine Market, Competitive Dashboard
  • Figure 105: Global Nasal Spray Influenza Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Nasal Spray Influenza Vaccine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 107: Global, Nasal Spray Influenza Vaccine Market Size Gain ($ Billion), Segmentation By Administration Method, 2025 – 2030
  • Figure 108: Global, Nasal Spray Influenza Vaccine Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Influenza Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric,...

Influenza Treatment Market Report 2026 - Global Outlook – By Product Type (Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, Other Products), By Route Of Administration (Oral, Other Routes Of Administratio...

Respiratory Disease Vaccine Market Report 2026 - Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other In...

Influenza Diagnostic Market Report 2026 - Global Outlook – By Traditional Diagnostic Tests (Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests ), By Molecu...

Swine Flu Vaccination Market Report 2026 - Global Outlook – By Vaccine Type (Intranasal, Toxoid, Conjugate, Inactivated Vaccine, Attenuated Vaccine, Other Vaccine Type), By Treatment Type (Influenza, Live Attenuated Infl...

Nasal Spray Bottle Market Report 2026 - Global Outlook – By Product Type (Saline Nasal Spray, Decongestion Nasal Spray, Steroid Nasal Spray, Antihistamine Nasal Spray), By Container Design (Pump Bottles, Pressurized Cani...

Anthrax Vaccine Market Report 2026 - Global Outlook – By Vaccine Type (Cell-Free Protective Antigen (PA) Vaccine, Live Attenuated Vaccine), By Application Type (Animal Use, Human Use), By Distribution Channel (Hospitals,...

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

Frequently Asked Questions

The Nasal Spray Influenza Vaccine market was valued at $1.48 billion in 2025, increased to $1.66 billion in 2026, and is projected to reach $2.68 billion by 2030.

The global Nasal Spray Influenza Vaccine market is expected to grow at a CAGR of 12.7% from 2026 to 2035 to reach $2.68 billion by 2035.

Some Key Players in the Nasal Spray Influenza Vaccine market Include, Sanofi Pasteur SA, GSK plc, FluGen Inc., BioDiem Ltd, Codagenix Inc, Altimmune Inc, AstraZeneca PLC, MedImmune LLC, BCHT Biotechnology Co Ltd, Serum Institute of India Pvt Ltd, Vivaldi Biosciences, Vaccitech, Blue Water Vaccines, VaxInnate, INOVIO Pharmaceuticals, Cipla Ltd, Beijing Wantai Biological Pharmacy Enterprise Co Ltd, Bharat Biotech, Novavax Inc, BioNTech SE, Transgene SA, BiondVax Pharmaceuticals Ltd, Adimmune Corporation, Teva Pharmaceutical Industries Ltd .

Major trend in this market includes: The Role Of Live Attenuated Influenza Vaccines In Immune Response. For further insights on this market. request a sample here

North America was the largest region in the nasal spray influenza vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nasal spray influenza vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us